United States

People: Interleukin Genetics Inc (ILIU.PK)

ILIU.PK on OTC Markets Group

26 May 2017
Change (% chg)

$-0.00 (-3.33%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Kornman, Kenneth 

Dr. Kenneth S. Kornman Ph.D. DDS is President, Chief Scientific Officer, Director of the Company. Dr. Kornman also served as our Chief Executive Officer from August 2012 through April 2015. He has also been a member of our Board of Directors since August 2012 and previously served as a director from August 2006 through April 2010. Prior to founding Interleukin in 1986, Dr. Kornman was a Department Chairman and Professor at The University of Texas Health Center at San Antonio. He has also been a consultant and scientific advisor for several major oral care and pharmaceutical companies. Dr. Kornman currently retains academic appointments at Harvard University and the University of Michigan. He holds multiple patents in the molecular diagnostics area, has published three books and more than 125 scientific papers and has lectured and consulted worldwide on the transfer of technology to clinical practice. Dr. Kornman also holds an M.S. (Periodontics) and Ph.D. (Microbiology-Immunology) from the University of Michigan.

Basic Compensation

Total Annual Compensation, USD 405,450
Restricted Stock Awards, USD --
Long-Term Incentive Plans, USD --
All Other, USD 506,976
Fiscal Year Total, USD 912,426

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --